P
Phio Pharmaceuticals Corp. Common StockPHIO
Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biopharmaceutical company advancing its proprietary INTASYL® siRNA gene silencing technology to eliminate cancer. Phio's INTASYL compounds are designed to enhance the body's immune cells to more effectively kill cancer.
US StocksHealthcareSmall CapBiotechnology
PHIO の価格トレンド
Phio Pharmaceuticals Corp. Common Stock · TradingView フルチャート
NASDAQ:PHIO